118 related articles for article (PubMed ID: 10520726)
21. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
Salmi P; Ahlenius S
Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
[TBL] [Abstract][Full Text] [Related]
22. Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine.
Dias FR; de Matos LW; Dos Santos Sampaio Mde F; Carey RJ; Carrera MP
Psychopharmacology (Berl); 2013 Jan; 225(1):141-50. PubMed ID: 22825579
[TBL] [Abstract][Full Text] [Related]
23. Effect of pimozide on the increase of muscarinic receptors caused by mazindol and apomorphine in the rat cerebral motor cortex.
de-Sousa FC; Marinho MM; Aguiar GV; Viana GS
Braz J Med Biol Res; 1995 Jan; 28(1):113-9. PubMed ID: 7581019
[TBL] [Abstract][Full Text] [Related]
24. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
Serra G; Collu M; Gessa GL
Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
[TBL] [Abstract][Full Text] [Related]
25. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
Meller E; Hizami R; Kreuter L
Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521
[TBL] [Abstract][Full Text] [Related]
26. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
27. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
Kusumi I; Takahashi Y; Suzuki K; Kameda K; Koyama T
J Neural Transm (Vienna); 2000; 107(3):295-302. PubMed ID: 10821438
[TBL] [Abstract][Full Text] [Related]
29. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
[TBL] [Abstract][Full Text] [Related]
30. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Reuss B; Unsicker K
Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
[TBL] [Abstract][Full Text] [Related]
31. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
Menon MK; Gordon LI; Kodama CK; Fitten J
Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
[TBL] [Abstract][Full Text] [Related]
32. Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors.
Chaperon F; Tricklebank MD; Unger L; Neijt HC
Neuropharmacology; 2003 Jun; 44(8):1047-53. PubMed ID: 12763098
[TBL] [Abstract][Full Text] [Related]
33. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Ahnaou A; Megens AA; Drinkenburg WH
Neuropsychobiology; 2003; 48(1):47-54. PubMed ID: 12886041
[TBL] [Abstract][Full Text] [Related]
34. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
35. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
Nagashima M; Yamada K; Kimura H; Matsumoto S; Furukawa T
Pharmacol Biochem Behav; 1992 Dec; 43(4):993-7. PubMed ID: 1361996
[TBL] [Abstract][Full Text] [Related]
38. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
39. Apomorphine and pergolide induce hypothermia by stimulation of dopamine D-2 receptors.
Ogren SO; Fuxe K
Acta Physiol Scand; 1988 May; 133(1):91-5. PubMed ID: 3067517
[TBL] [Abstract][Full Text] [Related]
40. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
Dean B; Hussain T; Scarr E; Pavey G; Copolov DL
Life Sci; 2001 Aug; 69(11):1257-68. PubMed ID: 11521750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
